Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
|
| Income Taxes | ||||
| Company's effective tax rate | 0.00% | 0.00% | 0.00% | 0.00% |
| Percentage of ineligible annual research and development credit for cash | 65.00% | 65.00% | 65.00% | 65.00% |
| Income tax benefit | $ 0 | $ 0 | $ 0 | $ 0 |
| Income tax receivable related to R&D credit | $ 697 | $ 697 | ||
| X | ||||||||||
- Definition The amount of income taxes receivable related to research and development tax credit recorded as at the end of the reporting period. No definition available.
|
| X | ||||||||||
- Definition Percentage of the value of the unused research and development tax credits that are allowed to be exchanged for cash by qualified small companies conducting research and development in Connecticut under the Connecticut Research and Development Tax Credit Exchange Program. No definition available.
|
| X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|